Nexalin's neurostimulation device receives approval in Israel
PositiveFinancial Markets

Nexalin's neurostimulation device has received approval in Israel, marking a significant milestone for the company and the field of mental health treatment. This innovative device aims to provide a non-invasive solution for various mental health conditions, potentially improving the quality of life for many patients. The approval not only highlights the growing acceptance of neurostimulation technologies but also opens doors for further research and development in this promising area.
— Curated by the World Pulse Now AI Editorial System







